Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neoplasm, Residual × Zymosan × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Neoplasm, Residual 1

Interventions

venetoclax 1 fludarabine 1 asparaginase erwinia chrysanthemi recombinant 1 Zymosan 1 Idarubicin 1 Etoposide 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04674306 2025-05-23

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Active not recruiting

Neoplasm, Residual, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡